Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Shareholders Equity (Quarterly): 142.30M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 142.30M |
March 31, 2024 | 156.43M |
December 31, 2023 | 21.72M |
September 30, 2023 | 24.40M |
June 30, 2023 | 15.46M |
March 31, 2023 | 20.55M |
December 31, 2022 | 26.71M |
September 30, 2022 | 38.11M |
June 30, 2022 | -5.749M |
March 31, 2022 | 5.241M |
December 31, 2021 | 11.51M |
September 30, 2021 | 21.97M |
June 30, 2021 | 32.76M |
June 30, 2021 | 32.76M |
December 31, 2020 | 12.35M |
June 30, 2020 | 34.00M |
June 30, 2020 | 34.00M |
December 31, 2019 | 27.42M |
June 30, 2019 | 34.42M |
June 30, 2019 | 34.42M |
December 31, 2018 | 44.48M |
June 30, 2018 | 57.47M |
June 30, 2018 | 57.47M |
December 31, 2017 | 70.75M |
June 30, 2017 | 63.15M |
Date | Value |
---|---|
June 30, 2017 | 63.15M |
December 31, 2016 | 66.57M |
June 30, 2016 | 77.36M |
June 30, 2016 | 77.36M |
December 31, 2015 | 89.52M |
June 30, 2015 | 97.60M |
June 30, 2015 | 97.60M |
December 31, 2014 | 43.20M |
June 30, 2014 | 56.42M |
June 30, 2014 | 56.42M |
December 31, 2013 | 45.47M |
June 30, 2013 | 49.52M |
June 30, 2013 | 49.52M |
December 31, 2012 | 26.04M |
June 30, 2012 | 12.51M |
June 30, 2012 | 12.51M |
December 31, 2011 | 49.58M |
June 30, 2011 | 55.23M |
December 31, 2010 | 49.80M |
June 30, 2010 | 51.52M |
December 31, 2009 | 14.38M |
June 30, 2009 | 19.40M |
December 31, 2008 | 19.69M |
June 30, 2008 | 28.36M |
December 31, 2007 | 35.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.749M
Minimum
Jun 2022
156.43M
Maximum
Mar 2024
36.22M
Average
25.56M
Median
Shareholders Equity (Quarterly) Benchmarks
NuCana PLC | 4.806M |
TC BioPharm (Holdings) PLC | 1.364M |
Biodexa Pharmaceuticals PLC | 11.04M |
Adaptimmune Therapeutics PLC | 96.27M |
Verona Pharma PLC | 130.49M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 238.59M |
Total Liabilities (Quarterly) | 96.29M |
Current Ratio | 9.830 |